Recombinant Human PLCg1 Protein，His

PLCg1, or phospholipase C-gamma 1, is a crucial enzyme that plays a significant role in various intracellular signaling pathways, particularly in processes related to cell differentiation, proliferation, and apoptosis. It is involved in pathways activated by growth factor receptors and plays a pivotal role in the biology of immune cells and neuronal signaling. Research into PLCg1 has gained momentum due to its association with various diseases, including cancer and autoimmune disorders. The enzyme is activated through interactions with membrane receptors, leading to the generation of inositol trisphosphate and diacylglycerol, which in turn mobilize intracellular calcium and activate protein kinase C pathways. Dysregulation of PLCg1 activity can contribute to aberrant cell signaling and tumorigenesis, making it an attractive target for therapeutic intervention. Scientists have been focusing on the structural and functional characterization of PLCg1 recombinant proteins to better understand their roles and potential as drug targets. By utilizing recombinant DNA technology, researchers can produce PLCg1 in larger quantities and study its properties, interactions with other proteins, and regulatory mechanisms in detail, aiming to uncover novel approaches for treating diseases linked to this enzyme. The exploration of PLCg1 in disease contexts holds promise for developing targeted therapies and improving our understanding of cell signaling dynamics, ultimately contributing to advances in biomedical research and clinical applications.